๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity

โœ Scribed by Pawel Mielnik; Hanna Chwalinska-Sadowska; Ewa Wiesik-Szewczyk; Wlodzimierz Maslinski; Marzena Olesinska

Publisher
Springer
Year
2010
Tongue
English
Weight
159 KB
Volume
32
Category
Article
ISSN
0172-8172

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Serum levels of interleukin-2 receptor a
Serum levels of interleukin-2 receptor and disease activity in patients with iga nephropathy
โœ Dr. Yasuhiko Tomino; Teruyo Ozaki; Hikaru Koide; Masayoshi Takahashi; Kiichi Ito ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 1005 KB

The levels of serum interleukin-2 receptor (IL-2R) were studied by enzyme-linked immunosorbent assay (ELISA) in patients with IgA nephropathy. The aim of the present study was to determine if levels of serum IL-2R might correlate with disease activity in patients with IgA nephropathy. Twenty-eight p

Elevated serum levels of soluble interle
Elevated serum levels of soluble interleukin-2 receptor in patients with Wegener's granulomatosis. Association with disease activity
โœ Wilhelm H. Schmitt; Christoph Heesen; Elena Csernok; Annegret Rautmann; Wolfgang ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 770 KB

To investigate whether soluble interleukin-2 receptor (sIL-~R), a marker of T cell activation, could be a useful marker of disease activity in Wegener's granulomatosis (WG). Methods. Soluble IL-2R levels were determined by enzyme-linked immunosorbent assay. WG disease activity in 102 patients was a

Serum soluble TNF receptor I and II leve
Serum soluble TNF receptor I and II levels correlate with disease activity in IBD patients
โœ Tanja Spoettl; Martin Hausmann; Frank Klebl; Andrea Dirmeier; Bodo Klump; Joerg ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 170 KB

Background: Tumor necrosis factor alpha (TNFโฃ) is a proinflammatory cytokine and an important mediator in the pathophysiology of inflammatory bowel disease (IBD). The effects of TNFโฃ are mediated by 2 specific receptors, a 55-kDa protein (TNF-RI) and a 75-kDa receptor (TNF-RII), which are usually bo